Cargando…
HM1.24/BST-2 is constitutively poly-ubiquitinated at the N-terminal amino acid in the cytoplasmic domain
HM1.24 (also known as BST-2, CD317, and Tetherin) is a type II single-pass transmembrane glycoprotein, which traverses membranes using an N-terminal transmembrane helix and is anchored in membrane lipid rafts via a C-terminal glycosylphosphatidylinositol (GPI). HM1.24 plays a role in diverse cellula...
Autores principales: | Fujimoto, Keiko, Nakashima, Sanae, Uchida, Shotaro, Amen, Riham N.S., Ishii, Yuji, Hirota, Yuko, Tanaka, Yoshitaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374192/ https://www.ncbi.nlm.nih.gov/pubmed/32715103 http://dx.doi.org/10.1016/j.bbrep.2020.100784 |
Ejemplares similares
-
Targeted Therapy for HM1.24 (CD317) on Multiple Myeloma Cells
por: Harada, Takeshi, et al.
Publicado: (2014) -
The novel immunotoxin HM1.24-ETA′ induces apoptosis in multiple myeloma cells
por: Staudinger, M, et al.
Publicado: (2014) -
MT1-MMP Inhibits the Activity of Bst-2 via Their Cytoplasmic Domains Dependent Interaction
por: Fan, Long, et al.
Publicado: (2016) -
CpG oligodeoxynucleotides potentiate the antitumor activity of anti-BST2 antibody
por: Hiramatsu, Kosuke, et al.
Publicado: (2015) -
Cloning and Characterization of the Antiviral Activity of Feline Tetherin/BST-2
por: Fukuma, Aiko, et al.
Publicado: (2011)